chronic renal disease
Conditions
Interventions
Feedback of step data Goal setting for number of steps Linguistic praise
No intervention
Sponsors
Osaka Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Undergoing chronic hemodialysis therapy three times a week by commuting from home Able to walk independently Age 65 and older Have cognitively intact cohabitant(s) (any number of people) Obtained written consent from participants and their cohabitant(s).
Exclusion criteria
Exclusion criteria: Less than 6 months after commencement hemodialysis Unstable hemodialysis therapy condition Difficult-to-treat hypertension, cardiac disease, and lower extremity arterial lesions Active infectious diseases advanced malignant disease Patients deemed inappropriate for this study by the principal researcher or physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical function (grip strength, knee extension muscle strength) Evaluation period (3 times): pre-intervention, 3 months post-intervention, and 6 months post-intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Automatic measurement by Fitbit (number of steps, distance walked, energy expenditure, physical activity time, heart rate, sleep duration, skin temperature during sleep), age, gender, height, primary diseases, comorbidities, smoking, use of antihypertensive medications and sleeping pills, body weight (dry weight), creatinine, urea nitrogen (BUN), potassium (K), calcium (Ca), phosphorus (P), albumin (Alb), hemoglobin (Hb), C reactive protein (CRP), standardized protein catabolic rate (n-PCR), % creatinine production rate, quality of life, performance of daily activities Evaluation period (3 times): pre-intervention, 3 months post-intervention, and 6 months post-intervention. | — |
Countries
Japan
Contacts
Public ContactItoko Tobita
Osaka Medical and Pharmaceutical University Faculty of Nursing
Outcome results
None listed